在瘤中PGD2/PTGDR2信号通路的进展:一篇综述
Hengjin Tian1, Kunpeng Ge2, Lulu Wang3
1Department of Clinical Laboratory, The First Affiliated Hospital of Bengbu Medical University, Bengbu, China; Key Laboratory of Cancer Research and Clinical Laboratory Diagnosis, Bengbu Medical University, Bengbu, China.
前列腺素D2 (PGD2) 和它的受体PTGDR2抑制癌症的进展,并增强化疗. 降低的PGD2水平与几种癌症的预后不佳相关,突出了它们的治疗潜力.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 生物化学 生物化学
背景情况:
- 前列腺素 (PGs) 是过敏炎症和恶性疾病的关键媒介.
- 前列腺素E2 (PGE2) 和前列腺素D2 (PGD2) 信号通路对于癌症的发展和治疗至关重要.
- 已经证明PGD2及其受体PTGDR2在调节瘤生物学中起着重要的作用.
研究的目的:
- 在各种癌症中审查PGD2/PTGDR2的表达模式和生物活动.
- 探索PGD2及其受体作为瘤学治疗点的潜力.
- 确定未来研究癌症治疗中的PGD2/PTGDR2的关键问题.
主要方法:
- 在癌症中对PGD2/PTGDR2进行临床前和临床研究的文献综述.
- 对PGD2信号传递对癌细胞和瘤微环境的影响的实验数据的分析.
- 对PGD2表达水平与不同癌症类型患者预后的相关性分析.
主要成果:
- 通过PTGDR2传递PGD2信号,直接抑制癌细胞的存活,增殖和迁移.
- PGD2增强了对常规化疗剂的敏感性.
- PGD2通过影响化学激素和细胞激素分泌来调节瘤微环境 (TME),从而抑制瘤的进展.
- 减少PGD2表达与胃癌,乳腺癌,肺癌和胰腺癌的预后不佳有关.
结论:
- PGD2/PTGDR2信号表现出显著的抗瘤原源效应.
- PGD2/PTGDR2轴代表了新型癌症治疗的有希望的目标.
- 需要进一步的研究,以充分阐明和利用PGD2/PTGDR2在瘤学的治疗潜力.
更多相关视频
10:28Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Published on: January 22, 2018
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
相关概念视频
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
